Evidence map›Paper›PMID 38052970›Full record

ArticleScientific reports2023

Therapeutic interventions and the length of hospital stay for pediatric patients with COVID-19: a multicenter cohort study.

Tadashi Ishihara, Takashi Tagami, Atsushi Hirayama, Yuki Nakamura, Koichiro Sueyoshi, Ken Okamoto, Hiroshi Tanaka

Erratum issuedAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Tadashi IshiharaDepartment of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, 2-1-1, Tomioka, Urayasu-city, Chiba, 279-0021, Japan. ta-shi.0517@hotmail.co.jp.
Takashi TagamiDepartment of Emergency and Critical Care Medicine, Nippon Medical School Musashikosugi Hospital, Kawasaki-city, Kanagawa, Japan.
Atsushi HirayamaPublic Health, Department of Social Medicine, Graduate School of Medicine, Osaka University, Suita-city, Osaka, Japan.
Yuki NakamuraDepartment of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, 2-1-1, Tomioka, Urayasu-city, Chiba, 279-0021, Japan.
Koichiro SueyoshiDepartment of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, 2-1-1, Tomioka, Urayasu-city, Chiba, 279-0021, Japan.
Ken OkamotoDepartment of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, 2-1-1, Tomioka, Urayasu-city, Chiba, 279-0021, Japan.
Hiroshi TanakaDepartment of Emergency and Critical Care Medicine, Juntendo University, Urayasu Hospital, 2-1-1, Tomioka, Urayasu-city, Chiba, 279-0021, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The evidence for pediatric patients with COVID-19 was very limited, which was attributed to the small number of the cases as well as the rare incidence of severe pneumonia in this population. This retrospective cohort study aimed to identify the characteristics of pediatric patients with COVID-19 in the early period of the pandemic by analyzing Diagnosis Procedure Combination (DPC) data in Japan. This retrospective cohort analysis of Japanese multicenter research on COVID-19 using DPC data compared the outcomes and costs of treatment for pediatric patients with COVID-19. Of 4700 patients with COVID-19, 186 pediatric patients were included in this study. Among the included pediatric patients, 17 received therapeutic drugs specifically for COVID-19, while the remaining 169 pediatric patients received only symptomatic therapy. There were no significant differences in the length of hospital stay (9 vs. 8 days, p = 0.96), and medical cost (97,585 vs. 73,291 JPY) for the intervention and control groups, respectively by multiple regression analysis. This is the first epidemiological study to use DPC data to summarize the pathophysiology of pediatric patients in the early period of COVID-19 pandemic. There was no significant difference in length of hospital stay or medical cost by intervention.

Indexed as

COVID-19ChildCohort StudiesHumansLength of StayPandemicsRetrospective Studies

Identifiers

PMID38052970
PMCPMC10697937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.